Showing 101 - 120 results of 8,417 for search '"NK cells"', query time: 0.32s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104

    Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. by Galea-Lauri, J, Darling, D, Gan, S, Krivochtchapov, L, Kuiper, M, Gäken, J, Souberbielle, B, Farzaneh, F

    Published 1999
    “…The ability of NK cells to kill tumor cells is controlled by a balance between activating and inhibitory signals transduced by distinct receptors. …”
    Journal article
  5. 105
  6. 106
  7. 107
  8. 108
  9. 109

    The Role of HLAC and NK Cells in Fetal Growth Restriction by Sri Sulistyawati, Didon M Trimulya, Supriyadi H Respati, Soetrisno Soetrisno

    Published 2017-11-01
    “…Objective: To determine the role of HLA-C and NK cell expressions in fetal growth restriction (FGR). …”
    Get full text
    Article
  10. 110
  11. 111
  12. 112
  13. 113
  14. 114
  15. 115
  16. 116

    The Emerging Role of NK Cells in Immune Checkpoint Blockade by Alejandra Martinez-Perez, Candelaria Aguilar-Garcia, Segundo Gonzalez

    Published 2022-12-01
    “…Natural killer (NK) cells are innate cytotoxic immune cells that play a fundamental role in anti-tumor immunity, particularly in hematological cancers, disseminated cancers, and metastasis [...]…”
    Get full text
    Article
  17. 117
  18. 118

    The Advances and Challenges of CAR-NK Cells for Tumor Immunotherapy by Ye Ziyun A.

    Published 2019-01-01
    “…To establish a more mature therapy, CAR incorporated into Natural Killer (NK) cells came into being. As a leukocyte involved in innate immunity, NK cell does not require MHC matching, making the production of allogeneic “off-the-shelf” CAR-NK cells possible. …”
    Get full text
    Article
  19. 119
  20. 120

    iPSCs in NK Cell Manufacturing and NKEV Development by Nicholas Boyd-Gibbins, Peter Karagiannis, Do Won Hwang, Shin-Il Kim, Shin-Il Kim

    Published 2022-07-01
    “…Natural killer (NK) cell immunotherapies for cancer can complement existing T cell therapies while benefiting from advancements already made in the immunotherapy field. …”
    Get full text
    Article